Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker
Aims This study aimed to evaluate the expression of nuclear survivin in adenoid cystic carcinoma (ACC) of the lacrimal gland and to determine if this expression is associated with histopathological features, markers of apoptosis and proliferation or clinical outcomes. Methods and results Immunohisto...
Saved in:
Published in | Histopathology Vol. 62; no. 6; pp. 840 - 846 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.05.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aims
This study aimed to evaluate the expression of nuclear survivin in adenoid cystic carcinoma (ACC) of the lacrimal gland and to determine if this expression is associated with histopathological features, markers of apoptosis and proliferation or clinical outcomes.
Methods and results
Immunohistochemical staining for survivin, p53, Ki‐67 and Bcl‐2 was analyzed in 55 cases of ACC of lacrimal gland. Thirty‐one cases (56.3%) expressed nuclear survivin. All cases expressed p53, Ki‐67 and Bcl‐2. Eleven cases (35.5%) had a high nuclear survivin score (NS‐SCORE) and 20 cases (64.5%) had a low NS‐SCORE. Cases with a high NS‐SCORE had a shorter progression‐free survival (PFS) (P < 0.0001), higher expression of Ki‐67 (P < 0.005) and a solid tumour pattern >30% (P < 0.005).
Conclusion
Nuclear expression of survivin impacts prognosis significantly and is thus a promising prognostic marker in ACC of the lacrimal gland. |
---|---|
Bibliography: | ArticleID:HIS12073 istex:79527B2DD2773BDAC2E5DC5B424A6F834D325B95 ark:/67375/WNG-CGRTS3VQ-G ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0309-0167 1365-2559 |
DOI: | 10.1111/his.12073 |